FinHealth

FinHealth

FinHealth operates from São Paulo and Rio de Janeiro, run by senior partners Luis Claudio Garcia de Souza and Marcio Garcia de Souza. The firm splits investment oversight along two sector verticals: Luis Claudio leads financial-services strategy and co-leads health sciences, while Marcio oversees compliance and real-estate-linked exposures. Its website describes a deliberate sector focus, arguing that specialist conviction produces higher hit rates than generalist managers can achieve. In healthcare and life sciences, FinHealth targets commercial and pre-commercial companies spanning specialty hospitals, diagnostics, biopharma for human and animal health, clinical research organizations, digital health tools, and medical devices. On the financial-services side, the firm launched original businesses that use innovative capital-markets instruments to challenge legacy bank offerings, then later shifted toward digitally native and data-science-driven models, often with a real-estate angle. The firm states it provides back-office infrastructure and embeds its own professionals directly into investee operations — a structure visible in its allocation of partner Augusto Carvalho as CFO and Matías Fernando Cristóbal Vidal as co-founder/CEO at portfolio company Securitas BioSciences. FinHealth’s team spans senior directors, an ANBIMA-certified operations and legal partner in Gabriel Rodolfo Ramos, and a CFO, Marcelo de Andrade. The firm maintains a secondary office in Rio de Janeiro and lists a contact email under the domain finvest.com.br, suggesting a shared-services or group-company infrastructure. No recent operational events were verifiable from public sources; the most recent structural evidence is the ongoing deployment of named partners into Securitas BioSciences. FinHealth’s structural differentiator is its operational-embedding model: the firm doesn’t just fund companies — it seats its own partners in C-suite roles at investees, turning the fund into a quasi-operating company. This model blurs the line between asset manager and holding company, a posture that is unusual among Brazilian venture managers.